Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

February 08, 2018

In Re Synergy Pharmaceuticals Inc. Securities Litigation

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. December 07, 2018

    Synergy Pharma Looks To Ditch Suit Over Side Effects, Loan

    Synergy Pharmaceuticals Inc. asked a New York federal judge on Thursday to toss an investor suit accusing the company of driving up its stock price by misrepresenting the side effect profile of its flagship medication and the terms of a $300 million private equity loan, saying no misstatements were ever made.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login